Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04025190 · ClinicalTrials.gov registry record

Assessing the Feasibility of Screening and Treating Anxiety and Depression in the Bone Marrow Transplant Population

A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
20
Enrollment target

NCT04025190 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04025190 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The primary purpose of this study is twofold: (1) to assess the feasibility of screening adult hematopoietic stem cell transplantation (HSCT) candidates for psychiatric comorbidity (depression and anxiety), and (2) to assess the feasibility of treating depression and anxiety in adult HSCT candidates through a collaborative care algorithm. The ultimate goal of this project is improving HSCT outcomes for allogeneic HSCT candidates by improving identification and treatment of depression and anxiety disorders.

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-02-22
Est. Completion 2018-08-28

What the Registry Record Tells You About NCT04025190

The ClinicalTrials.gov registry entry for NCT04025190 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04025190 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04025190 about?

NCT04025190 is a clinical study titled "Assessing the Feasibility of Screening and Treating Anxiety and Depression in the Bone Marrow Transplant Population". The primary purpose of this study is twofold: (1) to assess the feasibility of screening adult hematopoietic stem cell transplantation (HSCT) candidates for psychiatric comorbidity (depression and anxiety), and (2) to assess the feasibility of treating depression and anxiety in adult HSCT candidates...

What is the current status of trial NCT04025190?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-02-22. Estimated completion is 2018-08-28.

Who is sponsoring clinical trial NCT04025190?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.